{
    "title": "Can pharma\u2019s golden boy Sir Andrew Witty shine again after GlaxoSmithKline's China fiasco?",
    "url": "https://www.dailymail.co.uk/money/markets/article-2762766/Can-Sir-Andrew-Witty-shine-GlaxoSmithKlines-China-fiasco.html",
    "date": "2014-09-19",
    "keywords": [
        "boy",
        "executive",
        "industry",
        "growth",
        "gsk",
        "sir",
        "shine",
        "etain",
        "lavelle",
        "mail",
        "gmt",
        "september",
        "email",
        "view",
        "lustre",
        "chief",
        "industrys",
        "work",
        "group",
        "university",
        "nottingham",
        "africa",
        "asia",
        "head",
        "region",
        "glaxo",
        "corruption",
        "time",
        "job",
        "jp",
        "garnier",
        "predecessor",
        "ceos",
        "haughty",
        "glass",
        "office",
        "favour",
        "groundfloor",
        "desk",
        "canteen",
        "approach",
        "minister",
        "david",
        "cameron",
        "economy",
        "pharma",
        "witty",
        "adviser",
        "government",
        "role",
        "july",
        "bribery",
        "research",
        "development",
        "business",
        "bid",
        "productivity",
        "biotech",
        "intention",
        "withstand",
        "patent",
        "advair",
        "asthma",
        "price",
        "europe",
        "revenue",
        "focus",
        "cadre",
        "middleclass",
        "india",
        "model",
        "reform",
        "debaclei",
        "transparent",
        "year"
    ],
    "category": [
        "money",
        "markets"
    ]
}